IOBTQ (IO Biotech) Accounts Payable: $5.59 Mil (As of Sep. 2025)


What is IO Biotech Accounts Payable?

IO Biotech IOBTQ +27.50% Accounts Payable is $5.59 Mil as of Sep. 2025. The stock has 1 warning sign investors should review.

IO Biotech's Accounts Payable for the quarter that ended in Sep. 2025 was $5.59 Mil.

IO Biotech's quarterly Accounts Payable increased from Mar. 2025 ($5.20 Mil) to Jun. 2025 ($5.54 Mil) and increased from Jun. 2025 ($5.54 Mil) to Sep. 2025 ($5.59 Mil).

IO Biotech's annual Accounts Payable declined from Dec. 2022 ($4.00 Mil) to Dec. 2023 ($3.88 Mil) but then increased from Dec. 2023 ($3.88 Mil) to Dec. 2024 ($4.66 Mil).

IO Biotech Accounts Payable Historical Data

* Premium members only.

The historical data trend for IO Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IO Biotech Accounts Payable Chart

IO Biotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial 0.52 3.93 4.00 3.88 4.66

IO Biotech Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.26 4.66 5.20 5.54 5.59

IO Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $5.59 Mil mean?
IO Biotech (IOBTQ) has a Accounts Payable of $5.59 Mil as of Sep. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on IO Biotech and its competitors.
Is IO Biotech's Accounts Payable too high?
IO Biotech's current Accounts Payable is $5.59 Mil.
How does IO Biotech's Accounts Payable compare to CNBX and ENDV?
IO Biotech's Accounts Payable of $5.59 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on IO Biotech and its competitors. IO Biotech's current Accounts Payable is $5.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IO Biotech stock overvalued right now?
IO Biotech (IOBTQ) has a current Accounts Payable of $5.59 Mil. The current Accounts Payable is $5.59 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For IO Biotech (IOBTQ), the current Accounts Payable is $5.59 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IO Biotech Business Description

Address Ole Maaloes Vej 3, Copenhagen N, DNK, DK-2200
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.